Related Experiment Video
Updated: Jul 6, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
A statistical methodology for drug-drug interaction surveillance
G Niklas Norén1, Rolf Sundberg, Andrew Bate
1WHO Collaborating Centre for International Drug Monitoring in Uppsala, Uppsala, Sweden. niklas.noren@who-umc.org
Statistics in Medicine
|March 18, 2008
Summary
This study introduces a new method to detect drug-drug interactions using individual case safety reports (ICSRs). The approach improves identification of adverse drug reactions (ADRs) missed by traditional methods.
Area of Science:
- Pharmacovigilance
- Drug Safety
- Computational Pharmacology
Background:
- Drug interactions pose significant risks for adverse drug reactions (ADRs).
- Individual case safety reports (ICSRs) are valuable for post-marketing surveillance but underutilized for drug-drug interaction (DDI) detection.
- Existing DDI detection methods may fail due to assumptions about risk factor interactions.
Purpose of the Study:
- To implement and evaluate a novel shrinkage observed-to-expected ratio method for exploratory DDI analysis in ICSR data.
- To compare the proposed method against an additive risk model and logistic regression for DDI detection.
- To demonstrate the feasibility of a database-wide screen for suspected DDIs.
Main Methods:
- Application of a shrinkage observed-to-expected ratio for analyzing ICSR data.
- Comparison of the proposed method with an additive risk model and logistic regression.
- A comprehensive database-wide screen of the WHO database for suspected DDIs.
Main Results:
- The proposed method successfully identified established drug-drug interactions.
- Empirical examples show that the new approach detects DDIs missed by logistic regression.
- The method demonstrates feasibility for large-scale DDI screening.
Conclusions:
- The shrinkage observed-to-expected ratio offers an improved approach for DDI detection in ICSR data.
- This method addresses limitations of previous DDI detection techniques.
- Expert clinical validation is crucial for hypotheses generated by this pharmacovigilance tool.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:14Agonism and Antagonism: Quantification
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...